You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

neovascular AMD

Showing 1 - 25 of 1,072
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neovascular Age-related Macular Degeneration Trial (Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule,

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule
  • Intravitreal injections of 6 mg faricimab on a home optical coherence tomography-guided treatment schedule
  • (no location specified)
Jun 6, 2023

Subjects Diagnosed With Neovascular-AMD

Recruiting
  • Retinal Neovascularization
    • Boston, Massachusetts
    • +2 more
    Dec 6, 2022

    Age-Related Macular Degeneration Trial in Hong Kong (Brolucizumab, Aflibercept)

    Recruiting
    • Age-Related Macular Degeneration
    • Hong Kong, Hong Kong
      Grantham Hospital
    Jan 25, 2023

    Age-Related Macular Degeneration Trial (KH631)

    Not yet recruiting
    • Age-Related Macular Degeneration
    • (no location specified)
    Dec 10, 2022

    Retinal Revascularization and Clinical Indicators of Neovascular

    Recruiting
    • Wet Macular Degeneration
    • Ophthalmic Drugs
    • Arendal, Agder, Norway
      Sorlandet Hospital HF
    Mar 3, 2022

    Macular Degeneration Trial (Zimura, Avastin, Lucentis)

    Completed
    • Macular Degeneration
    • (no location specified)
    Oct 4, 2022

    Macular Degeneration, Wet, Metamorphopsia Trial

    Recruiting
    • Macular Degeneration, Wet
    • Metamorphopsia
      • Cuneo, Piedmont, Italy
        Ospedale Santa Croce
      Sep 20, 2022

      Wet Macular Degeneration, Neovascular Age-related Macular Degeneration, Macular Degeneration Trial in Czechia, Poland, Slovakia

      Recruiting
      • Wet Macular Degeneration
      • +2 more
      • Brno, Czechia
      • +15 more
      Jan 25, 2023

      Neovascular Age-related Macular Degeneration Trial in Seoul (Eylea, ALT-L9)

      Completed
      • Neovascular Age-related Macular Degeneration
      • Eylea
      • ALT-L9
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Jan 14, 2022

      Neovascular Age-related Macular Degeneration Trial in United States (CLS-AX, Anti-VEGF)

      Completed
      • Neovascular Age-related Macular Degeneration
      • Phoenix, Arizona
      • +10 more
      Dec 1, 2022

      Maximum Treatment Interval With Aflibercept T&E

      Recruiting
      • Neovascular Age-related Macular Degeneration
      • Aflibercept Injection [Eylea]
      • Taipei, Taiwan
        Shin Kong Memorial Wu Ho-Su Hospital
      Apr 19, 2022

      OCT Angiography in Wet AMD

      Recruiting
      • Neovascular (Wet) Age-related Macular Degeneration (AMD)
      • Optical Coherence Tomography
      • Portland, Oregon
        Casey Eye Institute, Oregon Health & Science University
      Sep 20, 2022

      Neovascular Age-related Macular Degeneration Trial in Shanghai (IBI302 (the first dose level), IBI302 (the second dose level),

      Completed
      • Neovascular Age-related Macular Degeneration
      • IBI302 (the first dose level)
      • +2 more
      • Shanghai, Shanghai, China
        Shanghai General Hospital
      Nov 10, 2021

      Neovascular Age-related Macular Degeneration Trial (FT-003)

      Not yet recruiting
      • Neovascular Age-related Macular Degeneration
      • FT-003
      • (no location specified)
      Nov 21, 2022

      Exudative Macular Degeneration Trial in Vienna (anti-VEGF agent)

      Recruiting
      • Exudative Macular Degeneration
      • anti-VEGF agent
      • Vienna, Austria
        Department of Ophthalmology, Medical University of Vienna, Austr
      Oct 13, 2021

      Defining Disease Activity in Neovascular AMD With Optical

      Recruiting
      • Neovascular Age-related Macular Degeneration
        • London, United Kingdom
          Moorfields Eye Hospital NHS Foundation Trust, 162 City Road
        Aug 19, 2021

        Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in San Antonio (D-4517.2)

        Recruiting
        • Neovascular Age-related Macular Degeneration
        • Diabetic Macular Edema
        • Los Angeles, California
        • +11 more
        Jan 11, 2023

        Neovascular Age-related Macular Degeneration Trial in Oslo (Zoledronic Acid 5 MG in 5 ML Injection, Placebos)

        Recruiting
        • Neovascular Age-related Macular Degeneration
        • Zoledronic Acid 5 MG in 5 ML Injection
        • Placebos
        • Oslo, Norway
        • +1 more
        Jan 12, 2022

        Neovascular Age-related Macular Degeneration

        Completed
        • Age-related Macular Degeneration (AMD)
        • East Hanover, New Jersey
          Novartis Investigative Site
        Dec 15, 2021

        Macula; Degeneration, Retina Trial in Tucson (carbidopa-levodopa 25-100 mg)

        Completed
        • Macula; Degeneration
        • Retina
        • carbidopa-levodopa 25-100 mg
        • Tucson, Arizona
          Robert W Snyder, MD, PhD, PC
        Dec 10, 2020

        Neovascular Age-related Macular Degeneration

        Completed
        • Age-related Macular Degeneration (AMD)
        • East Hanover, New Jersey
          Novartis Pharmaceuticals
        Oct 19, 2021

        Ocular Adverse Events in Neovascular Agerelated Macular

        Completed
        • Age-related Macular Degeneration (AMD)
        • Aflibercept
        • +2 more
        • East Hanover, New Jersey
          Novartis Investigative Site
        Dec 15, 2021

        Age-related Macular Degeneration Trial in Tucson (carbidopa-levodopa 25-100 mg tablets)

        Completed
        • Age-related Macular Degeneration
        • carbidopa-levodopa 25-100 mg tablets
        • Tucson, Arizona
          Robert W Snyder, MD, PhD, PC
        Dec 10, 2020

        Neovascular Age-related Macular Degeneration, Wet Age-related Macular Degeneration Trial in United States (RGX-314)

        Active, not recruiting
        • Neovascular Age-related Macular Degeneration
        • Wet Age-related Macular Degeneration
        • RGX-314
        • Santa Barbara, California
        • +7 more
        Apr 1, 2021

        Ocular Adverse Events in Neovascular Age-related Macular

        Completed
        • Age-related Macular Degeneration (AMD)
        • Aflibercept
        • +2 more
        • East Hanover, New Jersey
          Novartis Investigative Site
        Dec 15, 2021